(+)-catechin multiple interactions ISO RGD:1316466 6480464 [Oxygen deficiency co-treated with Catechin] results in decreased expression of SRXN1 mRNA CTD PMID:35883890 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SRXN1 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1614270 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SRXN1 mRNA CTD PMID:36331819 (E)-cinnamyl alcohol increases expression ISO RGD:1316466 6480464 cinnamyl alcohol results in increased expression of SRXN1 mRNA CTD PMID:20566472 (S)-colchicine increases expression ISO RGD:1614270 6480464 Colchicine results in increased expression of SRXN1 protein CTD PMID:27358234 1,2-dichloroethane increases expression ISO RGD:1614270 6480464 ethylene dichloride results in increased expression of SRXN1 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1614270 6480464 1, 2-Dimethylhydrazine results in decreased expression of SRXN1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1614270 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of SRXN1 mRNA] CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1316466 6480464 Dinitrochlorobenzene results in increased expression of SRXN1 mRNA CTD PMID:20566472 , PMID:25236440 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SRXN1 mRNA CTD PMID:20551477 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SRXN1 mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO RGD:1614270 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRXN1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1316466 6480464 Estradiol results in increased expression of SRXN1 mRNA CTD PMID:20106945 , PMID:31614463 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SRXN1 mRNA CTD PMID:32741896 17beta-estradiol affects expression ISO RGD:1316466 6480464 Estradiol affects the expression of SRXN1 mRNA CTD PMID:22574217 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SRXN1 mRNA CTD PMID:32741896 1H-pyrazole increases expression ISO RGD:1614270 6480464 pyrazole results in increased expression of SRXN1 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1614270 6480464 2 more ... CTD PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:1614270 6480464 2 more ... CTD PMID:21851831 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1316466 6480464 2 more ... CTD PMID:25305463 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1614270 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1614270 6480464 2 more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SRXN1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA CTD PMID:18796159 , PMID:27136898 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316466 6480464 Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1614270 6480464 Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1614270 6480464 Tetrachlorodibenzodioxin affects the expression of SRXN1 mRNA CTD PMID:20702594 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316466 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of SRXN1 mRNA CTD PMID:26159488 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1614270 6480464 2 more ... CTD PMID:20702594 2,4-D increases expression ISO RGD:1614270 6480464 2, 4-Dichlorophenoxyacetic Acid results in increased expression of SRXN1 mRNA CTD PMID:34626751 2,4-dinitrophenol increases expression ISO RGD:1614270 6480464 2, 4-Dinitrophenol results in increased expression of SRXN1 protein CTD PMID:27358234 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SRXN1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of SRXN1 mRNA CTD PMID:21346803 2-(chloromethyl)pyridine increases expression ISO RGD:1316466 6480464 2-chloromethylpyridine results in increased expression of SRXN1 mRNA CTD PMID:26198647 2-hydroxyethyl methacrylate increases expression ISO RGD:1316466 6480464 hydroxyethyl methacrylate results in increased expression of SRXN1 mRNA CTD PMID:30497689 2-hydroxypropanoic acid increases expression ISO RGD:1316466 6480464 Lactic Acid results in increased expression of SRXN1 mRNA CTD PMID:20566472 2-tert-butylhydroquinone increases expression ISO RGD:1614270 6480464 2-tert-butylhydroquinone results in increased expression of SRXN1 mRNA CTD PMID:16014739 , PMID:22003191 2-tert-butylhydroquinone increases expression ISO RGD:1316466 6480464 2-tert-butylhydroquinone results in increased expression of SRXN1 protein CTD PMID:35724838 2-tert-butylhydroquinone decreases expression ISO RGD:1316466 6480464 2-tert-butylhydroquinone results in decreased expression of SRXN1 mRNA CTD PMID:35724838 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1614270 6480464 tetrabromobisphenol A results in increased expression of SRXN1 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1614270 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SRXN1 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SRXN1 protein CTD PMID:34915118 3-Hydroxybenzo[a]pyrene increases expression ISO RGD:1316466 6480464 3-hydroxybenzo(a)pyrene results in increased expression of SRXN1 mRNA CTD PMID:26238291 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1316466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SRXN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SRXN1 mRNA CTD PMID:28628672 3-phenylprop-2-enal increases expression ISO RGD:1316466 6480464 cinnamaldehyde results in increased expression of SRXN1 mRNA CTD PMID:19000754 4,4'-methylene-bis-(2-chloroaniline) increases expression ISO RGD:1316466 6480464 Methylenebis(chloroaniline) results in increased expression of SRXN1 mRNA CTD PMID:26198647 4-hydroxynon-2-enal increases expression ISO RGD:1614270 6480464 4-hydroxy-2-nonenal results in increased expression of SRXN1 mRNA CTD PMID:19191707 , PMID:22003191 4-hydroxyphenyl retinamide increases expression ISO RGD:1614270 6480464 Fenretinide results in increased expression of SRXN1 mRNA CTD PMID:28973697 4-nitro-1,2-phenylenediamine increases expression ISO RGD:1316466 6480464 1, 2-diamino-4-nitrobenzene results in increased expression of SRXN1 mRNA CTD PMID:26198647 4-nitrophenol increases expression ISO RGD:1614270 6480464 4-nitrophenol results in increased expression of SRXN1 mRNA CTD PMID:22003191 4-nitroquinoline N-oxide increases expression ISO RGD:1614270 6480464 4-Nitroquinoline-1-oxide results in increased expression of SRXN1 mRNA CTD PMID:22003191 5-bromo-2'-deoxyuridine multiple interactions ISO RGD:1614270 6480464 [Bromodeoxyuridine co-treated with furan] results in increased expression of SRXN1 mRNA CTD PMID:24910943 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SRXN1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression ISO RGD:1614270 6480464 Propylthiouracil results in increased expression of SRXN1 protein CTD PMID:27358234 acetamide increases expression EXP 6480464 acetamide results in increased expression of SRXN1 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1316466 6480464 Acrylamide results in increased expression of SRXN1 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1316466 6480464 Aflatoxin B1 affects the expression of SRXN1 protein CTD PMID:20106945 aflatoxin B1 multiple interactions ISO RGD:1316466 6480464 [Plant Extracts co-treated with Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in decreased expression of SRXN1 mRNA CTD PMID:31904472 aflatoxin B1 increases methylation ISO RGD:1316466 6480464 Aflatoxin B1 results in increased methylation of SRXN1 intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:1316466 6480464 Aflatoxin B1 results in increased expression of SRXN1 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SRXN1 mRNA CTD PMID:22484513 more ... aflatoxin B1 decreases expression ISO RGD:1614270 6480464 Aflatoxin B1 results in decreased expression of SRXN1 mRNA CTD PMID:19770486 Aflatoxin B2 alpha multiple interactions ISO RGD:1316466 6480464 [Plant Extracts co-treated with Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in decreased expression of SRXN1 mRNA CTD PMID:31904472 Aflatoxin G1 multiple interactions ISO RGD:1316466 6480464 [Plant Extracts co-treated with Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in decreased expression of SRXN1 mRNA CTD PMID:31904472 Aflatoxin G2 multiple interactions ISO RGD:1316466 6480464 [Plant Extracts co-treated with Aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in decreased expression of SRXN1 mRNA CTD PMID:31904472 all-trans-retinoic acid increases expression ISO RGD:1316466 6480464 Tretinoin results in increased expression of SRXN1 mRNA CTD PMID:23724009 allyl alcohol increases expression ISO RGD:1614270 6480464 allyl alcohol results in increased expression of SRXN1 protein CTD PMID:27358234 alpha-hexylcinnamaldehyde increases expression ISO RGD:1316466 6480464 hexyl cinnamic aldehyde results in increased expression of SRXN1 mRNA CTD PMID:20566472 amoxicillin increases expression ISO RGD:1316466 6480464 Amoxicillin results in increased expression of SRXN1 mRNA CTD PMID:28444390 ampicillin decreases expression ISO RGD:1316466 6480464 Ampicillin results in decreased expression of SRXN1 mRNA CTD PMID:21632981 , PMID:26198647 andrographolide multiple interactions ISO RGD:1614270 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of SRXN1 mRNA CTD PMID:19737545 andrographolide multiple interactions ISO RGD:1316466 6480464 [andrographolide co-treated with TNF protein] results in increased expression of SRXN1 mRNA CTD PMID:35724838 andrographolide decreases expression ISO RGD:1316466 6480464 andrographolide results in decreased expression of SRXN1 mRNA CTD PMID:35724838 andrographolide increases expression ISO RGD:1316466 6480464 andrographolide results in increased expression of SRXN1 protein CTD PMID:35724838 andrographolide increases expression ISO RGD:1614270 6480464 andrographolide results in increased expression of SRXN1 mRNA CTD PMID:19737545 aphidicolin increases expression ISO RGD:1614270 6480464 Aphidicolin results in increased expression of SRXN1 mRNA CTD PMID:22003191 arachidonic acid increases expression EXP 6480464 Arachidonic Acid metabolite results in increased expression of SRXN1 mRNA CTD PMID:27012417 aristolochic acid A increases expression ISO RGD:1316466 6480464 aristolochic acid I results in increased expression of SRXN1 mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO RGD:1316466 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane multiple interactions ISO RGD:1614270 6480464 NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of SRXN1 mRNA] CTD PMID:23000044 arsane increases expression ISO RGD:1614270 6480464 Arsenic results in increased expression of SRXN1 mRNA CTD PMID:23000044 arsenic atom multiple interactions ISO RGD:1614270 6480464 NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of SRXN1 mRNA] CTD PMID:23000044 arsenic atom increases expression ISO RGD:1614270 6480464 Arsenic results in increased expression of SRXN1 mRNA CTD PMID:23000044 arsenite(3-) increases expression ISO RGD:1316466 6480464 arsenite results in increased expression of SRXN1 mRNA CTD PMID:22476201 arsenite(3-) multiple interactions ISO RGD:1316466 6480464 arsenite promotes the reaction [G3BP1 protein binds to SRXN1 mRNA] more ... CTD PMID:22476201 , PMID:32406909 arsenous acid increases expression ISO RGD:1316466 6480464 Arsenic Trioxide results in increased expression of SRXN1 mRNA CTD PMID:24356939 more ... arsenous acid multiple interactions ISO RGD:1316466 6480464 Ethionamide inhibits the reaction [Arsenic Trioxide results in increased expression of SRXN1 mRNA] CTD PMID:26708503 azathioprine increases expression ISO RGD:1316466 6480464 Azathioprine results in increased expression of SRXN1 mRNA CTD PMID:22623647 , PMID:26198647 azathioprine increases expression ISO RGD:1614270 6480464 Azathioprine results in increased expression of SRXN1 protein CTD PMID:27358234 Bandrowski's base increases expression ISO RGD:1316466 6480464 Bandrowski's base results in increased expression of SRXN1 mRNA CTD PMID:20566472 Bardoxolone methyl increases expression ISO RGD:1614270 6480464 bardoxolone methyl results in increased expression of SRXN1 protein CTD PMID:27358234 Bardoxolone methyl decreases expression ISO RGD:1316466 6480464 bardoxolone methyl results in decreased expression of SRXN1 mRNA CTD PMID:35724838 Bardoxolone methyl increases expression ISO RGD:1316466 6480464 bardoxolone methyl results in increased expression of SRXN1 mRNA, bardoxolone methyl results in increased expression of SRXN1 protein CTD PMID:34480604 , PMID:35724838 Bardoxolone methyl multiple interactions ISO RGD:1316466 6480464 NFE2L2 promotes the reaction [bardoxolone methyl results in increased expression of SRXN1 protein] CTD PMID:27358234 beauvericin multiple interactions ISO RGD:1316466 6480464 [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA more ... CTD PMID:31100301 , PMID:34015425 beauvericin decreases expression ISO RGD:1316466 6480464 beauvericin results in decreased expression of SRXN1 mRNA CTD PMID:34015425 benzene increases expression ISO RGD:1316466 6480464 Benzene results in increased expression of SRXN1 mRNA CTD PMID:19162166 benzidine increases expression ISO RGD:1316466 6480464 benzidine results in increased expression of SRXN1 mRNA CTD PMID:26198647 benzo[a]pyrene decreases expression ISO RGD:1316466 6480464 Benzo(a)pyrene results in decreased expression of SRXN1 protein CTD PMID:32717239 benzo[a]pyrene increases methylation ISO RGD:1316466 6480464 Benzo(a)pyrene results in increased methylation of SRXN1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1316466 6480464 Benzo(a)pyrene results in increased expression of SRXN1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:1614270 6480464 Benzo(a)pyrene results in increased expression of SRXN1 mRNA CTD PMID:19770486 more ... benzoic acid increases expression ISO RGD:1316466 6480464 Benzoic Acid results in increased expression of SRXN1 mRNA CTD PMID:20566472 beta-naphthoflavone multiple interactions ISO RGD:1614270 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of SRXN1 mRNA CTD PMID:19737545 beta-naphthoflavone increases expression ISO RGD:1316466 6480464 beta-Naphthoflavone results in increased expression of SRXN1 mRNA CTD PMID:32858204 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SRXN1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1614270 6480464 bisphenol A results in increased expression of SRXN1 mRNA CTD PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SRXN1 mRNA CTD PMID:34947998 bisphenol A affects expression ISO RGD:1316466 6480464 bisphenol A affects the expression of SRXN1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1316466 6480464 bisphenol A results in increased expression of SRXN1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1316466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SRXN1 mRNA CTD PMID:28628672 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SRXN1 gene CTD PMID:28505145 bisphenol F multiple interactions ISO RGD:1316466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SRXN1 mRNA CTD PMID:28628672 bleomycin A2 increases expression ISO RGD:1614270 6480464 Bleomycin results in increased expression of SRXN1 mRNA CTD PMID:22003191 bleomycin A5 increases expression ISO RGD:1316466 6480464 bleomycetin results in increased expression of SRXN1 mRNA CTD PMID:21040473 Bromochloroacetonitrile increases expression ISO RGD:1316466 6480464 bromochloroacetonitrile results in increased expression of SRXN1 mRNA CTD PMID:35842135 buta-1,3-diene increases expression ISO RGD:1614270 6480464 1, 3-butadiene results in increased expression of SRXN1 mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO RGD:1316466 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SRXN1 mRNA CTD PMID:29432896 butylated hydroxyanisole increases expression ISO RGD:1614270 6480464 Butylated Hydroxyanisole results in increased expression of SRXN1 protein CTD PMID:27358234 cadmium atom increases expression ISO RGD:1316466 6480464 Cadmium results in increased expression of SRXN1 mRNA CTD PMID:21120746 , PMID:21172416 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SRXN1 mRNA CTD PMID:19010381 cadmium dichloride increases expression ISO RGD:1316466 6480464 Cadmium Chloride results in increased expression of SRXN1 mRNA CTD PMID:25596134 cadmium dichloride increases expression ISO RGD:1614270 6480464 Cadmium Chloride results in increased expression of SRXN1 mRNA CTD PMID:22003191 , PMID:22677785 cadmium dichloride multiple interactions ISO RGD:1614270 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA], NFE2L2 protein affects the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA] CTD PMID:22003191 cadmium dichloride affects expression ISO RGD:1614270 6480464 Cadmium Chloride affects the expression of SRXN1 mRNA CTD PMID:18974090 cadmium sulfate increases expression ISO RGD:1614270 6480464 cadmium sulfate results in increased expression of SRXN1 mRNA CTD PMID:16221973 camptothecin increases expression ISO RGD:1614270 6480464 Camptothecin results in increased expression of SRXN1 mRNA CTD PMID:22003191 cannabidiol increases expression ISO RGD:1614270 6480464 Cannabidiol results in increased expression of SRXN1 mRNA CTD PMID:21542829 cannabidiol increases expression ISO RGD:1316466 6480464 Cannabidiol results in increased expression of SRXN1 mRNA CTD PMID:31518892 captan increases expression ISO RGD:1614270 6480464 Captan results in increased expression of SRXN1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1316466 6480464 Carbamazepine affects the expression of SRXN1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1614270 6480464 Nanotubes, Carbon results in increased expression of SRXN1 mRNA CTD PMID:25554681 cerium trichloride multiple interactions ISO RGD:1316466 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of SRXN1 mRNA CTD PMID:28954213 CHIR 99021 multiple interactions ISO RGD:1316466 6480464 [4-(2-(5 more ... CTD PMID:34480604 chlordecone increases expression ISO RGD:1614270 6480464 Chlordecone results in increased expression of SRXN1 mRNA CTD PMID:33711761 chloroacetaldehyde increases expression ISO RGD:1316466 6480464 chloroacetaldehyde results in increased expression of SRXN1 mRNA CTD PMID:25596134 Chloroacetonitrile increases expression ISO RGD:1316466 6480464 chloroacetonitrile results in increased expression of SRXN1 mRNA CTD PMID:35842135 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of SRXN1 mRNA CTD PMID:23125180 chloroprene increases expression ISO RGD:1614270 6480464 Chloroprene results in increased expression of SRXN1 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1614270 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SRXN1 mRNA CTD PMID:20938992 cidofovir anhydrous increases expression ISO RGD:1316466 6480464 Cidofovir results in increased expression of SRXN1 mRNA CTD PMID:25596134 ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of SRXN1 mRNA CTD PMID:22193206 cinnamyl alcohol increases expression ISO RGD:1316466 6480464 cinnamyl alcohol results in increased expression of SRXN1 mRNA CTD PMID:20566472 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SRXN1 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:1316466 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SRXN1 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1316466 6480464 Cisplatin results in increased expression of SRXN1 mRNA CTD PMID:19561079 more ... cisplatin decreases expression ISO RGD:1614270 6480464 Cisplatin results in decreased expression of SRXN1 mRNA CTD PMID:24865317 cisplatin multiple interactions ISO RGD:1614270 6480464 [Cisplatin co-treated with Lutein] results in decreased expression of SRXN1 mRNA CTD PMID:24865317 cisplatin increases expression ISO RGD:1614270 6480464 Cisplatin results in increased expression of SRXN1 mRNA CTD PMID:22003191 , PMID:34626751 clobetasol increases expression ISO RGD:1614270 6480464 Clobetasol results in increased expression of SRXN1 mRNA CTD PMID:27462272 clodronic acid increases expression ISO RGD:1316466 6480464 Clodronic Acid results in increased expression of SRXN1 mRNA CTD PMID:25596134 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SRXN1 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1316466 6480464 cobaltous chloride results in increased expression of SRXN1 mRNA CTD PMID:19320972 , PMID:22941251 copper atom increases expression ISO RGD:1316466 6480464 Copper results in increased expression of SRXN1 mRNA CTD PMID:19747488 copper atom multiple interactions ISO RGD:1316466 6480464 [NSC 689534 binds to Copper] which results in increased expression of SRXN1 mRNA more ... CTD PMID:19747488 , PMID:20971185 copper(0) increases expression ISO RGD:1316466 6480464 Copper results in increased expression of SRXN1 mRNA CTD PMID:19747488 copper(0) multiple interactions ISO RGD:1316466 6480464 [NSC 689534 binds to Copper] which results in increased expression of SRXN1 mRNA more ... CTD PMID:19747488 , PMID:20971185 copper(II) sulfate increases expression ISO RGD:1316466 6480464 Copper Sulfate results in increased expression of SRXN1 mRNA CTD PMID:19549813 copper(II) sulfate multiple interactions ISO RGD:1614270 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA], NFE2L2 protein affects the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA] CTD PMID:22003191 copper(II) sulfate increases expression ISO RGD:1614270 6480464 Copper Sulfate results in increased expression of SRXN1 mRNA CTD PMID:22003191 cortisol multiple interactions ISO RGD:1316466 6480464 [4-(2-(5 more ... CTD PMID:34480604 coumarin increases expression EXP 6480464 coumarin results in increased expression of SRXN1 mRNA CTD PMID:18480146 cyclosporin A increases expression ISO RGD:1316466 6480464 Cyclosporine results in increased expression of SRXN1 mRNA CTD PMID:20106945 more ... cypermethrin increases expression ISO RGD:1614270 6480464 cypermethrin results in increased expression of SRXN1 mRNA CTD PMID:21142847 cyproconazole increases expression ISO RGD:1614270 6480464 cyproconazole results in increased expression of SRXN1 mRNA CTD PMID:22334560 cytarabine increases expression ISO RGD:1614270 6480464 Cytarabine results in increased expression of SRXN1 mRNA CTD PMID:22003191 DDT increases expression ISO RGD:1316466 6480464 DDT results in increased expression of SRXN1 mRNA CTD PMID:26198647 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SRXN1 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:1316466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SRXN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SRXN1 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:1316466 6480464 Ethionamide inhibits the reaction [Arsenic Trioxide results in increased expression of SRXN1 mRNA] CTD PMID:26708503 diarsenic trioxide increases expression ISO RGD:1316466 6480464 Arsenic Trioxide results in increased expression of SRXN1 mRNA CTD PMID:24356939 more ... diazinon increases expression ISO RGD:1316466 6480464 Diazinon results in increased expression of SRXN1 mRNA CTD PMID:24356939 , PMID:26198647 dibenzo[a,l]pyrene decreases expression ISO RGD:1316466 6480464 dibenzo(a, l)pyrene results in decreased expression of SRXN1 mRNA CTD PMID:31255691 Dibromoacetonitrile increases expression ISO RGD:1316466 6480464 dibromoacetonitrile results in increased expression of SRXN1 mRNA CTD PMID:35842135 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SRXN1 mRNA CTD PMID:21266533 dicamba increases expression ISO RGD:1614270 6480464 Dicamba results in increased expression of SRXN1 mRNA CTD PMID:34626751 dichloroacetic acid increases expression ISO RGD:1614270 6480464 Dichloroacetic Acid results in increased expression of SRXN1 mRNA CTD PMID:28962523 Dichloroacetonitrile increases expression ISO RGD:1316466 6480464 dichloroacetonitrile results in increased expression of SRXN1 mRNA CTD PMID:35842135 diclofenac increases expression ISO RGD:1316466 6480464 Diclofenac results in increased expression of SRXN1 mRNA CTD PMID:24752500 diclofenac increases expression ISO RGD:1614270 6480464 Diclofenac results in increased expression of SRXN1 protein CTD PMID:27358234 diclofenac multiple interactions ISO RGD:1316466 6480464 NFE2L2 protein affects the reaction [Diclofenac results in increased expression of SRXN1 mRNA] CTD PMID:24752500 diethyl maleate increases expression ISO RGD:1614270 6480464 diethyl maleate results in increased expression of SRXN1 mRNA, diethyl maleate results in increased expression of SRXN1 protein CTD PMID:22003191 more ... diethyl maleate multiple interactions ISO RGD:1316466 6480464 [diethyl maleate co-treated with TNF protein] results in decreased expression of SRXN1 protein more ... CTD PMID:27982581 , PMID:35724838 diethyl maleate decreases expression ISO RGD:1316466 6480464 diethyl maleate results in decreased expression of SRXN1 mRNA CTD PMID:33545341 diethyl maleate increases expression ISO RGD:1316466 6480464 diethyl maleate results in increased expression of SRXN1 mRNA, diethyl maleate results in increased expression of SRXN1 protein CTD PMID:27982581 more ... diethyl maleate multiple interactions ISO RGD:1614270 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [diethyl maleate results in increased expression of SRXN1 mRNA], NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 mRNA] CTD PMID:22003191 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of SRXN1 mRNA CTD PMID:22193206 dioxygen decreases expression ISO RGD:1316466 6480464 Oxygen deficiency results in decreased expression of SRXN1 mRNA CTD PMID:25596134 , PMID:35883890 dioxygen multiple interactions ISO RGD:1316466 6480464 [Oxygen deficiency co-treated with Catechin] results in decreased expression of SRXN1 mRNA CTD PMID:35883890 diphenylcyclopropenone increases expression ISO RGD:1316466 6480464 diphenylcyclopropenone results in increased expression of SRXN1 mRNA CTD PMID:25236440 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:1316466 6480464 Antimony Potassium Tartrate results in increased expression of SRXN1 mRNA CTD PMID:28713220 diquat increases expression ISO RGD:1316466 6480464 Diquat results in increased expression of SRXN1 mRNA CTD PMID:21172416 diquat increases expression ISO RGD:1614270 6480464 Diquat results in increased expression of SRXN1 mRNA CTD PMID:36851058 disulfiram increases expression ISO RGD:1316466 6480464 Disulfiram results in increased expression of SRXN1 mRNA CTD PMID:20566472 diuron increases expression EXP 6480464 Diuron results in increased expression of SRXN1 mRNA CTD PMID:21551480 doramapimod increases expression ISO RGD:1614270 6480464 doramapimod results in increased expression of SRXN1 mRNA CTD PMID:21328587 dorsomorphin multiple interactions ISO RGD:1316466 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1614270 6480464 Doxorubicin results in increased expression of SRXN1 mRNA CTD PMID:22003191 endosulfan multiple interactions ISO RGD:1316466 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of SRXN1 mRNA CTD PMID:26159488 enniatin multiple interactions ISO RGD:1316466 6480464 [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA more ... CTD PMID:31100301 , PMID:34015425 entinostat increases expression ISO RGD:1316466 6480464 entinostat results in increased expression of SRXN1 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1614270 6480464 epoxiconazole results in increased expression of SRXN1 mRNA CTD PMID:22334560 , PMID:23970803 etacrynic acid increases expression ISO RGD:1316466 6480464 Ethacrynic Acid results in increased expression of SRXN1 protein CTD PMID:35724838 ethanol increases expression ISO RGD:1614270 6480464 Ethanol results in increased expression of SRXN1 mRNA CTD PMID:19167417 ethanol affects splicing ISO RGD:1614270 6480464 Ethanol affects the splicing of SRXN1 mRNA CTD PMID:30319688 ethionamide multiple interactions ISO RGD:1316466 6480464 Ethionamide inhibits the reaction [arsenic trioxide results in increased expression of SRXN1 mRNA] CTD PMID:26708503 etoposide increases expression ISO RGD:1614270 6480464 Etoposide results in increased expression of SRXN1 mRNA, Etoposide results in increased expression of SRXN1 protein CTD PMID:22003191 , PMID:27358234 etoposide multiple interactions ISO RGD:1316466 6480464 NFE2L2 protein affects the reaction [Etoposide results in increased expression of SRXN1 protein], TP53 protein affects the reaction [Etoposide results in increased expression of SRXN1 protein] CTD PMID:27982581 etoposide increases expression ISO RGD:1316466 6480464 Etoposide results in increased expression of SRXN1 protein CTD PMID:27982581 eugenol increases expression ISO RGD:1316466 6480464 Eugenol results in increased expression of SRXN1 mRNA CTD PMID:20566472 , PMID:26198647 fenamidone increases expression ISO RGD:1614270 6480464 fenamidone results in increased expression of SRXN1 mRNA CTD PMID:27029645 fenofibrate increases expression ISO RGD:1316466 6480464 Fenofibrate results in increased expression of SRXN1 mRNA CTD PMID:25596134 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SRXN1 mRNA CTD PMID:30307764 flucloxacillin increases expression ISO RGD:1316466 6480464 Floxacillin results in increased expression of SRXN1 mRNA CTD PMID:28444390 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SRXN1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1614270 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SRXN1 mRNA more ... CTD PMID:20938992 , PMID:22206623 folpet increases expression ISO RGD:1614270 6480464 folpet results in increased expression of SRXN1 mRNA CTD PMID:31558096 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of SRXN1 mRNA CTD PMID:18499655 , PMID:20884683 formaldehyde decreases expression ISO RGD:1316466 6480464 Formaldehyde results in decreased expression of SRXN1 mRNA CTD PMID:23649840 fumonisin B1 increases expression ISO RGD:1614270 6480464 fumonisin B1 results in increased expression of SRXN1 mRNA CTD PMID:16221962 furan multiple interactions ISO RGD:1614270 6480464 [Bromodeoxyuridine co-treated with furan] results in increased expression of SRXN1 mRNA CTD PMID:24910943 furan increases expression EXP 6480464 furan results in increased expression of SRXN1 mRNA CTD PMID:26194646 furan increases expression ISO RGD:1614270 6480464 furan results in increased expression of SRXN1 mRNA CTD PMID:24183702 , PMID:24910943 gamma-hexachlorocyclohexane increases expression ISO RGD:1316466 6480464 Hexachlorocyclohexane results in increased expression of SRXN1 mRNA CTD PMID:26198647 genistein increases expression ISO RGD:1316466 6480464 Genistein results in increased expression of SRXN1 mRNA CTD PMID:18847459 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SRXN1 mRNA CTD PMID:22061828 , PMID:33387578 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of SRXN1 mRNA CTD PMID:20621112 hexane increases expression ISO RGD:1316466 6480464 n-hexane results in increased expression of SRXN1 mRNA CTD PMID:20566472 hydralazine multiple interactions ISO RGD:1316466 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SRXN1 mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO RGD:1614270 6480464 Hydrogen Peroxide results in increased expression of SRXN1 mRNA CTD PMID:22003191 hydrogen peroxide affects expression ISO RGD:1316466 6480464 Hydrogen Peroxide affects the expression of SRXN1 mRNA CTD PMID:20044591 , PMID:23410634 hydroxyurea increases expression ISO RGD:1614270 6480464 Hydroxyurea results in increased expression of SRXN1 mRNA CTD PMID:22003191 hypochlorous acid increases expression ISO RGD:1614270 6480464 Hypochlorous Acid results in increased expression of SRXN1 mRNA CTD PMID:19376150 ibuprofen increases expression ISO RGD:1316466 6480464 Ibuprofen results in increased expression of SRXN1 mRNA CTD PMID:25596134 ifosfamide increases expression ISO RGD:1316466 6480464 Ifosfamide results in increased expression of SRXN1 mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:1316466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SRXN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SRXN1 mRNA CTD PMID:28628672 indometacin increases expression ISO RGD:1614270 6480464 Indomethacin results in increased expression of SRXN1 protein CTD PMID:27358234 isoeugenol increases expression ISO RGD:1316466 6480464 isoeugenol results in increased expression of SRXN1 mRNA CTD PMID:20566472 isoniazide increases expression ISO RGD:1316466 6480464 Isoniazid results in increased expression of SRXN1 mRNA CTD PMID:28444390 ivermectin decreases expression ISO RGD:1316466 6480464 Ivermectin results in decreased expression of SRXN1 protein CTD PMID:32959892 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of SRXN1 mRNA CTD PMID:36653537 L-ascorbic acid multiple interactions ISO RGD:1316466 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:1316466 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO RGD:1614270 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SRXN1 mRNA CTD PMID:20938992 lead diacetate increases expression ISO RGD:1614270 6480464 lead acetate results in increased expression of SRXN1 mRNA CTD PMID:25270620 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of SRXN1 mRNA CTD PMID:24136188 leflunomide increases expression ISO RGD:1316466 6480464 leflunomide results in increased expression of SRXN1 mRNA CTD PMID:28988120 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of SRXN1 mRNA CTD PMID:24136188 lipopolysaccharide increases expression ISO RGD:1614270 6480464 Lipopolysaccharides results in increased expression of SRXN1 mRNA CTD PMID:19339665 lipopolysaccharide multiple interactions ISO RGD:1316466 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide decreases response to substance ISO RGD:1614270 6480464 SRXN1 protein results in decreased susceptibility to Lipopolysaccharides CTD PMID:21083423 lipopolysaccharide multiple interactions ISO RGD:1614270 6480464 methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of SRXN1 mRNA] CTD PMID:19339665 lomustine increases expression ISO RGD:1614270 6480464 Lomustine results in increased expression of SRXN1 protein CTD PMID:27358234 lutein multiple interactions ISO RGD:1614270 6480464 [Cisplatin co-treated with Lutein] results in decreased expression of SRXN1 mRNA CTD PMID:24865317 lutein decreases expression ISO RGD:1614270 6480464 Lutein results in decreased expression of SRXN1 mRNA CTD PMID:24865317 menadione increases expression ISO RGD:1614270 6480464 Vitamin K 3 results in increased expression of SRXN1 mRNA CTD PMID:25270620 menadione increases expression ISO RGD:1316466 6480464 Vitamin K 3 results in increased expression of SRXN1 mRNA CTD PMID:23410634 mercury dibromide increases expression ISO RGD:1316466 6480464 mercuric bromide results in increased expression of SRXN1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1316466 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRXN1 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of SRXN1 mRNA CTD PMID:16507785 metam multiple interactions ISO RGD:1614270 6480464 methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of SRXN1 mRNA] CTD PMID:19339665 methapyrilene increases expression ISO RGD:1614270 6480464 Methapyrilene results in increased expression of SRXN1 protein CTD PMID:27358234 methyl methacrylate increases expression ISO RGD:1614270 6480464 Methylmethacrylate results in increased expression of SRXN1 mRNA CTD PMID:16916219 methyl methanesulfonate increases expression ISO RGD:1614270 6480464 Methyl Methanesulfonate results in increased expression of SRXN1 mRNA CTD PMID:22003191 methyl methanesulfonate multiple interactions ISO RGD:1614270 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA], NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA] CTD PMID:22003191 methyl salicylate increases expression ISO RGD:1316466 6480464 methyl salicylate results in increased expression of SRXN1 mRNA CTD PMID:20566472 methylisothiazolinone increases expression ISO RGD:1316466 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of SRXN1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1316466 6480464 methylmercuric chloride results in increased expression of SRXN1 mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:1316466 6480464 methylmercuric chloride results in decreased expression of SRXN1 mRNA CTD PMID:29581082 mitomycin C increases expression ISO RGD:1614270 6480464 Mitomycin results in increased expression of SRXN1 mRNA CTD PMID:22003191 morphine increases expression ISO RGD:1614270 6480464 Morphine results in increased expression of SRXN1 mRNA CTD PMID:20144693 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SRXN1 mRNA CTD PMID:28659758 N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide multiple interactions ISO RGD:1316466 6480464 N-(3, 5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of SRXN1 mRNA] CTD PMID:19747488 N-acetyl-L-cysteine multiple interactions ISO RGD:1614270 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA] more ... CTD PMID:22003191 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1614270 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SRXN1 mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:1316466 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SRXN1 mRNA CTD PMID:24810058 N-methylformamide affects expression ISO RGD:1614270 6480464 methylformamide affects the expression of SRXN1 mRNA, methylformamide analog affects the expression of SRXN1 mRNA CTD PMID:17040096 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of SRXN1 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions ISO RGD:1614270 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SRXN1 mRNA CTD PMID:24535843 n-propyl gallate increases expression ISO RGD:1614270 6480464 Propyl Gallate results in increased expression of SRXN1 mRNA CTD PMID:22003191 naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of SRXN1 mRNA CTD PMID:24976557 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SRXN1 mRNA CTD PMID:24136188 nickel sulfate increases expression ISO RGD:1316466 6480464 nickel sulfate results in increased expression of SRXN1 mRNA CTD PMID:20566472 nickel sulfate decreases expression ISO RGD:1316466 6480464 nickel sulfate results in decreased expression of SRXN1 mRNA CTD PMID:22714537 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of SRXN1 mRNA CTD PMID:24136188 nitrososulfamethoxazole increases expression ISO RGD:1316466 6480464 4-nitrososulfamethoxazole results in increased expression of SRXN1 mRNA CTD PMID:28444390 ochratoxin A multiple interactions ISO RGD:1316466 6480464 [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA more ... CTD PMID:34015425 ochratoxin A increases expression ISO RGD:1316466 6480464 ochratoxin A results in increased expression of SRXN1 mRNA CTD PMID:32905824 ochratoxin A decreases expression ISO RGD:1316466 6480464 ochratoxin A results in decreased expression of SRXN1 mRNA CTD PMID:34015425 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SRXN1 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1614270 6480464 Ozone results in increased expression of SRXN1 mRNA CTD PMID:17095637 ozone multiple interactions ISO RGD:1614270 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SRXN1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SRXN1 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:1316466 6480464 p-Chloromercuribenzoic Acid results in increased expression of SRXN1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1316466 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRXN1 mRNA CTD PMID:27188386 paclitaxel increases expression ISO RGD:1614270 6480464 Paclitaxel results in increased expression of SRXN1 mRNA CTD PMID:22003191 paracetamol affects expression ISO RGD:1614270 6480464 Acetaminophen affects the expression of SRXN1 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:1614270 6480464 PANX1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of SRXN1 mRNA] CTD PMID:29246445 paracetamol increases expression ISO RGD:1614270 6480464 Acetaminophen results in increased expression of SRXN1 mRNA, Acetaminophen results in increased expression of SRXN1 protein CTD PMID:27358234 , PMID:29246445 paracetamol increases expression ISO RGD:1316466 6480464 Acetaminophen results in increased expression of SRXN1 mRNA CTD PMID:21420995 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SRXN1 mRNA CTD PMID:17202762 , PMID:33387578 paraquat multiple interactions ISO RGD:1614270 6480464 APOD protein affects the reaction [Paraquat results in increased expression of SRXN1 mRNA] CTD PMID:21688324 paraquat multiple interactions ISO RGD:1316466 6480464 [Paraquat co-treated with Antigens, Dermatophagoides] results in increased expression of SRXN1 mRNA CTD PMID:34097952 paraquat increases expression ISO RGD:1316466 6480464 Paraquat results in increased expression of SRXN1 mRNA CTD PMID:34097952 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SRXN1 mRNA CTD PMID:32680482 paraquat increases expression ISO RGD:1614270 6480464 Paraquat results in increased expression of SRXN1 mRNA CTD PMID:21688324 pentachlorophenol increases expression ISO RGD:1614270 6480464 Pentachlorophenol results in increased expression of SRXN1 mRNA CTD PMID:23892564 perfluorohexanesulfonic acid increases expression ISO RGD:1614270 6480464 perfluorohexanesulfonic acid results in increased expression of SRXN1 mRNA CTD PMID:28558994 perfluorohexanesulfonic acid multiple interactions ISO RGD:1614270 6480464 PPARA protein affects the reaction [perfluorohexanesulfonic acid results in increased expression of SRXN1 mRNA] CTD PMID:28558994 perfluorononanoic acid increases expression ISO RGD:1614270 6480464 perfluoro-n-nonanoic acid results in increased expression of SRXN1 mRNA CTD PMID:28558994 perfluorononanoic acid increases expression ISO RGD:1316466 6480464 perfluoro-n-nonanoic acid results in increased expression of SRXN1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1614270 6480464 perfluorooctane sulfonic acid results in increased expression of SRXN1 mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1614270 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SRXN1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SRXN1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1614270 6480464 perfluorooctanoic acid results in increased expression of SRXN1 mRNA CTD PMID:28558994 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SRXN1 mRNA CTD PMID:28659758 permethrin increases expression ISO RGD:1614270 6480464 Permethrin results in increased expression of SRXN1 mRNA CTD PMID:30629241 phenobarbital multiple interactions ISO RGD:1614270 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SRXN1 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SRXN1 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1614270 6480464 Phenobarbital results in increased expression of SRXN1 mRNA, Phenobarbital results in increased expression of SRXN1 protein CTD PMID:19270015 more ... phenobarbital affects expression ISO RGD:1316466 6480464 Phenobarbital affects the expression of SRXN1 mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:1614270 6480464 Phenobarbital affects the expression of SRXN1 mRNA CTD PMID:19136022 phenol increases expression ISO RGD:1316466 6480464 Phenol results in increased expression of SRXN1 mRNA CTD PMID:26198647 phenylmercury acetate increases expression ISO RGD:1316466 6480464 Phenylmercuric Acetate results in increased expression of SRXN1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1316466 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRXN1 mRNA CTD PMID:27188386 phorone affects expression EXP 6480464 phorone affects the expression of SRXN1 mRNA CTD PMID:18198479 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of SRXN1 mRNA CTD PMID:22484513 pirinixic acid affects expression ISO RGD:1614270 6480464 pirinixic acid affects the expression of SRXN1 mRNA CTD PMID:19136022 pirinixic acid increases expression ISO RGD:1614270 6480464 pirinixic acid results in increased expression of SRXN1 mRNA CTD PMID:16221962 more ... pirinixic acid multiple interactions ISO RGD:1614270 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of SRXN1 mRNA], PPARA protein promotes the reaction [pirinixic acid results in increased expression of SRXN1 mRNA] CTD PMID:16221962 , PMID:20059764 pirinixic acid decreases expression ISO RGD:1614270 6480464 pirinixic acid results in decreased expression of SRXN1 mRNA CTD PMID:20813756 potassium bromate increases expression ISO RGD:1614270 6480464 potassium bromate results in increased expression of SRXN1 mRNA CTD PMID:22003191 potassium bromate increases expression ISO RGD:1316466 6480464 potassium bromate results in increased expression of SRXN1 mRNA CTD PMID:30008028 prednisolone increases expression ISO RGD:1316466 6480464 Prednisolone results in increased expression of SRXN1 mRNA CTD PMID:24356939 propan-2-ol increases expression ISO RGD:1316466 6480464 2-Propanol results in increased expression of SRXN1 mRNA CTD PMID:20566472 propiconazole increases expression ISO RGD:1614270 6480464 propiconazole results in increased expression of SRXN1 mRNA CTD PMID:21278054 , PMID:22334560 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SRXN1 mRNA CTD PMID:28659758 quercetin affects expression EXP 6480464 Quercetin affects the expression of SRXN1 mRNA CTD PMID:18178720 quinolin-8-ol increases expression ISO RGD:1316466 6480464 Oxyquinoline results in increased expression of SRXN1 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1316466 6480464 Lactic Acid results in increased expression of SRXN1 mRNA CTD PMID:20566472 reactive oxygen species multiple interactions ISO RGD:1614270 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA] more ... CTD PMID:22003191 resorcinol increases expression ISO RGD:1614270 6480464 resorcinol results in increased expression of SRXN1 mRNA CTD PMID:22003191 rotenone increases expression ISO RGD:1614270 6480464 Rotenone results in increased expression of SRXN1 mRNA CTD PMID:23186747 rotenone decreases expression ISO RGD:1316466 6480464 Rotenone results in decreased expression of SRXN1 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1316466 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of SRXN1 mRNA CTD PMID:36576512 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1316466 6480464 [S-(1 more ... CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:1614270 6480464 Buthionine Sulfoximine results in increased expression of SRXN1 protein CTD PMID:27358234 SB 431542 multiple interactions ISO RGD:1316466 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 silicon dioxide increases expression ISO RGD:1614270 6480464 Silicon Dioxide results in increased expression of SRXN1 mRNA CTD PMID:19073995 silver atom increases expression ISO RGD:1316466 6480464 Silver results in increased expression of SRXN1 mRNA CTD PMID:26014281 , PMID:28959546 silver atom increases expression ISO RGD:1614270 6480464 Silver results in increased expression of SRXN1 mRNA CTD PMID:27131904 silver atom affects expression ISO RGD:1614270 6480464 Silver affects the expression of SRXN1 mRNA CTD PMID:19429238 silver(0) affects expression ISO RGD:1614270 6480464 Silver affects the expression of SRXN1 mRNA CTD PMID:19429238 silver(0) increases expression ISO RGD:1614270 6480464 Silver results in increased expression of SRXN1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1316466 6480464 Silver results in increased expression of SRXN1 mRNA CTD PMID:26014281 , PMID:28959546 sodium arsenite decreases expression ISO RGD:1316466 6480464 sodium arsenite results in decreased expression of SRXN1 mRNA CTD PMID:22714537 sodium arsenite increases expression ISO RGD:1614270 6480464 sodium arsenite results in increased expression of SRXN1 mRNA CTD PMID:16014739 more ... sodium arsenite affects expression ISO RGD:1614270 6480464 sodium arsenite affects the expression of SRXN1 mRNA CTD PMID:16507464 sodium arsenite multiple interactions ISO RGD:1614270 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [sodium arsenite results in increased expression of SRXN1 mRNA], NFE2L2 protein affects the reaction [sodium arsenite results in increased expression of SRXN1 mRNA] CTD PMID:22003191 sodium arsenite increases expression ISO RGD:1316466 6480464 sodium arsenite results in increased expression of SRXN1 mRNA CTD PMID:20100676 more ... sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of SRXN1 mRNA CTD PMID:25993096 sodium dodecyl sulfate increases expression ISO RGD:1316466 6480464 Sodium Dodecyl Sulfate results in increased expression of SRXN1 mRNA CTD PMID:20566472 Soman increases expression EXP 6480464 Soman results in increased expression of SRXN1 mRNA CTD PMID:19281266 sotorasib multiple interactions ISO RGD:1316466 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SRXN1 mRNA CTD PMID:36139627 streptozocin multiple interactions ISO RGD:1614270 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of SRXN1 mRNA more ... CTD PMID:32410268 succimer multiple interactions ISO RGD:1614270 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRXN1 mRNA CTD PMID:21641980 sulfisoxazole increases expression ISO RGD:1614270 6480464 Sulfisoxazole results in increased expression of SRXN1 mRNA CTD PMID:22003191 sulforaphane increases expression ISO RGD:1316466 6480464 sulforaphane results in increased expression of SRXN1 mRNA, sulforaphane results in increased expression of SRXN1 protein CTD PMID:26833863 more ... sulforaphane decreases expression ISO RGD:1316466 6480464 sulforaphane results in decreased expression of SRXN1 mRNA CTD PMID:35724838 sulindac increases expression ISO RGD:1614270 6480464 Sulindac results in increased expression of SRXN1 protein CTD PMID:27358234 sunitinib increases expression ISO RGD:1316466 6480464 Sunitinib results in increased expression of SRXN1 mRNA CTD PMID:31533062 tert-butyl hydroperoxide increases expression ISO RGD:1614270 6480464 tert-Butylhydroperoxide results in increased expression of SRXN1 mRNA CTD PMID:22003191 tert-butyl hydroperoxide increases expression ISO RGD:1316466 6480464 tert-Butylhydroperoxide results in increased expression of SRXN1 mRNA CTD PMID:23410634 , PMID:27509014 tert-butyl hydroperoxide decreases methylation ISO RGD:1316466 6480464 tert-Butylhydroperoxide results in decreased methylation of SRXN1 gene CTD PMID:27509014 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SRXN1 mRNA CTD PMID:32741896 tetrachloroethene increases expression ISO RGD:1614270 6480464 Tetrachloroethylene results in increased expression of SRXN1 mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:1614270 6480464 Carbon Tetrachloride affects the expression of SRXN1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SRXN1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SRXN1 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1614270 6480464 Carbon Tetrachloride results in increased expression of SRXN1 mRNA CTD PMID:27339419 , PMID:31919559 thapsigargin increases expression ISO RGD:1614270 6480464 Thapsigargin results in increased expression of SRXN1 protein CTD PMID:27358234 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SRXN1 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of SRXN1 mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SRXN1 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:1316466 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SRXN1 mRNA CTD PMID:36139627 trans-isoeugenol increases expression ISO RGD:1316466 6480464 isoeugenol results in increased expression of SRXN1 mRNA CTD PMID:20566472 Trichloroacetonitrile increases expression ISO RGD:1316466 6480464 trichloroacetonitrile results in increased expression of SRXN1 mRNA CTD PMID:35842135 trichloroethene increases expression ISO RGD:1614270 6480464 Trichloroethylene results in increased expression of SRXN1 mRNA CTD PMID:19448997 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SRXN1 mRNA CTD PMID:33387578 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of SRXN1 mRNA CTD PMID:30589522 Triptolide increases expression ISO RGD:1614270 6480464 triptolide results in increased expression of SRXN1 mRNA CTD PMID:32835833 troglitazone increases expression ISO RGD:1316466 6480464 troglitazone results in increased expression of SRXN1 mRNA CTD PMID:19140230 tunicamycin increases expression ISO RGD:1614270 6480464 Tunicamycin results in increased expression of SRXN1 protein CTD PMID:27358234 tunicamycin increases expression ISO RGD:1316466 6480464 Tunicamycin results in increased expression of SRXN1 mRNA CTD PMID:36586010 urethane increases expression ISO RGD:1316466 6480464 Urethane results in increased expression of SRXN1 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:1316466 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SRXN1 mRNA CTD PMID:17183730 valproic acid affects expression ISO RGD:1316466 6480464 Valproic Acid affects the expression of SRXN1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1316466 6480464 Valproic Acid results in increased expression of SRXN1 mRNA CTD PMID:23179753 more ... XAV939 multiple interactions ISO RGD:1316466 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mRNA CTD PMID:34480604 zearalenone decreases expression ISO RGD:1316466 6480464 Zearalenone results in decreased expression of SRXN1 mRNA CTD PMID:34015425 zearalenone multiple interactions ISO RGD:1316466 6480464 [Plant Extracts co-treated with Zearalenone] results in decreased expression of SRXN1 mRNA, [Zearalenone co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA CTD PMID:34015425 zinc oxide multiple interactions ISO RGD:1614270 6480464 Zinc Oxide affects the splicing of and results in increased expression of SRXN1 mRNA CTD PMID:30500950